EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation

Xinjun Lu, Qi Zhu, Junfeng Cai, Zuozhong Yang, Guangxiang Gu, Li Pang, Mingye Su, Fapeng Zhang, Haoming Lin, Wenrui Wu, Leibo Xu, Chao Liu

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03853-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Xinjun Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Graft Rejection. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Science and Technology Program of Guangzhou, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularLiver NeoplasmsGraft RejectionImmunotherapyHumansMaleFemaleMiddle AgedRetrospective StudiesImmune Checkpoint InhibitorsAdultAgedNeoplasm InvasivenessSurvival Rate

Stichwörter der Autor:innen

Acute rejectionHCCImmune checkpoint inhibitorLiver transplantationMVI

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Pancreatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. liuchao3@mail.sysu.edu.cn.

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Science and Technology Program of Guangzhou
  • Natural Science Foundation of China
  • Sun Yat-sen Pilot Scientific Research Fund
  • Sun Yat-Sen University Clinical Research 5010 Program
  • Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program
  • Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer

Zitieren

APA

Lu, X., Zhu, Q., Cai, J., Yang, Z., Gu, G., Pang, L., Su, M., Zhang, F., Lin, H., Wu, W., Xu, L., & Liu, C. (2024). Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03853-9

Vancouver

Lu X, Zhu Q, Cai J, Yang Z, Gu G, Pang L, et al. Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03853-9

BibTeX
@article{Lu2024,
  author = {Lu, Xinjun and Zhu, Qi and Cai, Junfeng and Yang, Zuozhong and Gu, Guangxiang and Pang, Li and Su, Mingye and Zhang, Fapeng and Lin, Haoming and Wu, Wenrui and Xu, Leibo and Liu, Chao},
  title = {Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03853-9}
}
Kostenlos starten →